Concepts (150)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Biocompatible Materials | 13 | 2019 | 233 | 4.090 |
Why?
|
| Tissue Engineering | 11 | 2017 | 659 | 2.120 |
Why?
|
| Regenerative Medicine | 5 | 2019 | 202 | 1.910 |
Why?
|
| Prostheses and Implants | 2 | 2015 | 47 | 0.850 |
Why?
|
| Nanoparticles | 3 | 2019 | 56 | 0.760 |
Why?
|
| Materials Testing | 4 | 2017 | 92 | 0.710 |
Why?
|
| Tissue Scaffolds | 5 | 2017 | 421 | 0.680 |
Why?
|
| Nanomedicine | 1 | 2019 | 16 | 0.620 |
Why?
|
| Developing Countries | 1 | 2018 | 56 | 0.560 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2018 | 81 | 0.540 |
Why?
|
| Heart Diseases | 1 | 2018 | 116 | 0.530 |
Why?
|
| Toxicity Tests | 1 | 2014 | 13 | 0.440 |
Why?
|
| Journal Impact Factor | 1 | 2014 | 11 | 0.440 |
Why?
|
| Editorial Policies | 1 | 2014 | 14 | 0.440 |
Why?
|
| Terminology as Topic | 1 | 2014 | 64 | 0.430 |
Why?
|
| Leadership | 1 | 2014 | 40 | 0.430 |
Why?
|
| Polypropylenes | 1 | 2014 | 7 | 0.430 |
Why?
|
| Nerve Regeneration | 1 | 2014 | 49 | 0.420 |
Why?
|
| Publishing | 1 | 2014 | 62 | 0.420 |
Why?
|
| Animals | 13 | 2017 | 7569 | 0.410 |
Why?
|
| Peripheral Nerves | 1 | 2014 | 63 | 0.410 |
Why?
|
| Surgical Mesh | 1 | 2014 | 49 | 0.410 |
Why?
|
| Periodicals as Topic | 1 | 2014 | 91 | 0.400 |
Why?
|
| Humans | 22 | 2019 | 32798 | 0.350 |
Why?
|
| Cell Adhesion | 1 | 2011 | 103 | 0.340 |
Why?
|
| Peptides | 1 | 2011 | 125 | 0.330 |
Why?
|
| Metals | 1 | 2009 | 17 | 0.300 |
Why?
|
| Hip Prosthesis | 1 | 2009 | 16 | 0.300 |
Why?
|
| Polymers | 3 | 2015 | 66 | 0.280 |
Why?
|
| Research | 1 | 2008 | 76 | 0.270 |
Why?
|
| Platelet-Rich Plasma | 2 | 2014 | 12 | 0.220 |
Why?
|
| Postural Balance | 1 | 2016 | 180 | 0.210 |
Why?
|
| Pesticides | 1 | 2016 | 196 | 0.200 |
Why?
|
| Occupational Exposure | 1 | 2016 | 231 | 0.200 |
Why?
|
| Osteoarthritis | 2 | 2014 | 79 | 0.200 |
Why?
|
| Emigrants and Immigrants | 1 | 2016 | 240 | 0.200 |
Why?
|
| Chondrogenesis | 2 | 2013 | 20 | 0.190 |
Why?
|
| Transients and Migrants | 1 | 2016 | 298 | 0.190 |
Why?
|
| Aging | 3 | 2014 | 938 | 0.190 |
Why?
|
| Prosthesis Design | 3 | 2015 | 102 | 0.180 |
Why?
|
| Stem Cells | 2 | 2014 | 314 | 0.170 |
Why?
|
| Drug Delivery Systems | 2 | 2012 | 105 | 0.160 |
Why?
|
| Hispanic Americans | 1 | 2016 | 930 | 0.160 |
Why?
|
| Heart Valve Prosthesis | 2 | 2015 | 60 | 0.150 |
Why?
|
| History, 21st Century | 2 | 2009 | 61 | 0.140 |
Why?
|
| History, 20th Century | 2 | 2009 | 73 | 0.140 |
Why?
|
| Bone Regeneration | 2 | 2016 | 33 | 0.140 |
Why?
|
| Chondrocytes | 2 | 2014 | 69 | 0.130 |
Why?
|
| Models, Animal | 1 | 2017 | 171 | 0.130 |
Why?
|
| Doxorubicin | 2 | 2013 | 83 | 0.120 |
Why?
|
| Bone and Bones | 1 | 2016 | 94 | 0.110 |
Why?
|
| International Agencies | 1 | 2015 | 10 | 0.110 |
Why?
|
| Heart Valves | 1 | 2015 | 16 | 0.110 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2015 | 84 | 0.110 |
Why?
|
| Hyaluronic Acid | 1 | 2014 | 54 | 0.110 |
Why?
|
| Algorithms | 1 | 2017 | 511 | 0.110 |
Why?
|
| Adjuvants, Immunologic | 1 | 2014 | 54 | 0.110 |
Why?
|
| RNA Interference | 1 | 2014 | 77 | 0.110 |
Why?
|
| Cell Culture Techniques | 1 | 2015 | 172 | 0.100 |
Why?
|
| Heart-Assist Devices | 1 | 2015 | 54 | 0.100 |
Why?
|
| Foreign Bodies | 1 | 2014 | 30 | 0.100 |
Why?
|
| Mannose | 1 | 2013 | 1 | 0.100 |
Why?
|
| Granzymes | 1 | 2013 | 6 | 0.100 |
Why?
|
| Polyethyleneimine | 1 | 2013 | 2 | 0.100 |
Why?
|
| Micelles | 1 | 2013 | 4 | 0.100 |
Why?
|
| Surface Properties | 2 | 2012 | 36 | 0.100 |
Why?
|
| Carbamates | 1 | 2013 | 15 | 0.100 |
Why?
|
| Adipose Tissue | 2 | 2014 | 349 | 0.100 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2013 | 37 | 0.100 |
Why?
|
| Extracellular Matrix | 2 | 2013 | 243 | 0.100 |
Why?
|
| Fetal Blood | 1 | 2013 | 38 | 0.100 |
Why?
|
| Calcitonin | 1 | 2012 | 4 | 0.100 |
Why?
|
| Capsid | 1 | 2012 | 8 | 0.100 |
Why?
|
| Capsid Proteins | 1 | 2012 | 9 | 0.100 |
Why?
|
| Ferric Compounds | 1 | 2012 | 15 | 0.100 |
Why?
|
| Cyclic AMP | 1 | 2012 | 45 | 0.090 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2013 | 82 | 0.090 |
Why?
|
| MAP Kinase Signaling System | 1 | 2012 | 65 | 0.090 |
Why?
|
| Cytokines | 1 | 2013 | 247 | 0.090 |
Why?
|
| Diagnostic Imaging | 1 | 2012 | 97 | 0.090 |
Why?
|
| Osteoporosis | 1 | 2012 | 71 | 0.090 |
Why?
|
| Cells, Cultured | 4 | 2014 | 820 | 0.090 |
Why?
|
| Oligopeptides | 1 | 2011 | 43 | 0.090 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2013 | 182 | 0.090 |
Why?
|
| Inflammation | 1 | 2014 | 536 | 0.080 |
Why?
|
| Biomimetics | 1 | 2009 | 6 | 0.080 |
Why?
|
| Nanotechnology | 1 | 2009 | 18 | 0.080 |
Why?
|
| Nanostructures | 1 | 2009 | 21 | 0.080 |
Why?
|
| Genetic Vectors | 1 | 2009 | 120 | 0.070 |
Why?
|
| Prosthesis Failure | 1 | 2009 | 51 | 0.070 |
Why?
|
| Equipment Design | 1 | 2009 | 179 | 0.070 |
Why?
|
| Americas | 1 | 2008 | 6 | 0.070 |
Why?
|
| Asia | 1 | 2008 | 19 | 0.070 |
Why?
|
| Equipment and Supplies | 1 | 2008 | 16 | 0.070 |
Why?
|
| Europe | 1 | 2008 | 83 | 0.070 |
Why?
|
| Congresses as Topic | 1 | 2008 | 42 | 0.070 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 599 | 0.070 |
Why?
|
| Cell Differentiation | 3 | 2014 | 467 | 0.060 |
Why?
|
| Neoplasms | 1 | 2014 | 761 | 0.060 |
Why?
|
| Mice | 3 | 2014 | 2511 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2016 | 876 | 0.050 |
Why?
|
| Bone Marrow Cells | 2 | 2014 | 123 | 0.050 |
Why?
|
| Polyurethanes | 1 | 2002 | 5 | 0.050 |
Why?
|
| Cell Line | 2 | 2013 | 433 | 0.040 |
Why?
|
| North Carolina | 1 | 2016 | 1546 | 0.040 |
Why?
|
| Adult | 3 | 2016 | 9560 | 0.040 |
Why?
|
| Female | 4 | 2016 | 20261 | 0.040 |
Why?
|
| Aged | 2 | 2016 | 10538 | 0.030 |
Why?
|
| Middle Aged | 2 | 2016 | 12125 | 0.030 |
Why?
|
| Tensile Strength | 1 | 2015 | 56 | 0.030 |
Why?
|
| Perfusion | 1 | 2015 | 74 | 0.030 |
Why?
|
| Cattle | 1 | 2015 | 108 | 0.030 |
Why?
|
| Bioreactors | 1 | 2015 | 61 | 0.030 |
Why?
|
| Injections, Intra-Articular | 1 | 2014 | 16 | 0.030 |
Why?
|
| Polyesters | 1 | 2015 | 78 | 0.030 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2015 | 62 | 0.030 |
Why?
|
| Adipogenesis | 1 | 2014 | 30 | 0.030 |
Why?
|
| Sheep | 1 | 2015 | 233 | 0.030 |
Why?
|
| Osteogenesis | 1 | 2014 | 81 | 0.030 |
Why?
|
| Cell Survival | 1 | 2015 | 280 | 0.030 |
Why?
|
| Adipocytes | 1 | 2014 | 84 | 0.030 |
Why?
|
| Collagen | 1 | 2015 | 219 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2013 | 51 | 0.020 |
Why?
|
| Male | 2 | 2016 | 19641 | 0.020 |
Why?
|
| Phenotype | 1 | 2015 | 638 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2013 | 71 | 0.020 |
Why?
|
| Particle Size | 1 | 2013 | 47 | 0.020 |
Why?
|
| Plasmids | 1 | 2013 | 45 | 0.020 |
Why?
|
| Neoplasms, Experimental | 1 | 2013 | 30 | 0.020 |
Why?
|
| Cartilage | 1 | 2013 | 31 | 0.020 |
Why?
|
| Apoptosis | 1 | 2015 | 362 | 0.020 |
Why?
|
| Drug Carriers | 1 | 2013 | 24 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2013 | 58 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2013 | 72 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2012 | 52 | 0.020 |
Why?
|
| Kinetics | 1 | 2013 | 205 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2012 | 35 | 0.020 |
Why?
|
| Transfection | 1 | 2013 | 184 | 0.020 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2012 | 28 | 0.020 |
Why?
|
| Immunoassay | 1 | 2012 | 16 | 0.020 |
Why?
|
| Cell Death | 1 | 2012 | 71 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2012 | 57 | 0.020 |
Why?
|
| Antigens, CD34 | 1 | 2012 | 58 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2012 | 71 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2012 | 255 | 0.020 |
Why?
|
| Ovariectomy | 1 | 2012 | 162 | 0.020 |
Why?
|
| DNA | 1 | 2013 | 218 | 0.020 |
Why?
|
| Models, Biological | 1 | 2013 | 392 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2013 | 726 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 1307 | 0.020 |
Why?
|